Sort
30,917 grants matching “tumor microenvironment”
Lymph node-targeted molecular vaccines
$348,829Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2019 · EB
Integrative approach to identify genomic features that shape the immune landscape and predict immunotherapy response in diffuse large B cell lymphoma
$348,827Justin P. Kline · University Of Chicago · R01 · FY2024 · CA
Elucidation and therapeutic exploitation of PAK mediated radioresistance
$348,825Sunil J Advani · University Of California, San Diego · R37 · FY2019 · CA
Regulatory Immune Cell Networks in Cancer
$348,790Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2012 · CA
Regulatory Immune Cell Networks in Cancer
$348,790Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2011 · CA
Label-Free, Longitudinal, Multi-Metric Viability Imaging of 3D Tissue Spheroid Array
$348,786Jonghwan Lee · Brown University · R01 · FY2025 · CA
Targeting antigen presentation to improve immunotherapy responses in breast cancer
$348,754Justin M Balko · Vanderbilt University Medical Center · P50 · FY2020 · CA
Role of obesity as a causative factor of breast cancer in women of African American ethnicity
$348,753Deepa Bedi · Tuskegee University · U54 · FY2025 · MD
Conditional Knockout of Calcium Receptors in Bone Cells
$348,750Dolores M Shoback · Northern California Institute/Res/Edu · R01 · FY2009 · AR
Myeloid Suppressor Cell-Mediated Immune Suppression of Tumor Specific T Cells
$348,662Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
Myeloid Suppressor Cell-Mediated Immune Suppression of Tumor Specific T Cells
$348,662Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · CA
Myeloid Suppressor Cell-Mediated Immune Suppression of Tumor Specific T Cells
$348,662Shu-Hsia Chen · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
$348,600Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
Role of miR-105 in breast cancer metastasis
$348,600Shizhen Emily Wang · Beckman Research Institute/City Of Hope · R01 · FY2015 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
$348,600Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2012 · CA
Neuropeptide Y (NPY) as a hypoxia-driven metastatic factor
$348,597Joanna B Kitlinska · Georgetown University · R01 · FY2017 · CA
CAREER: Prediction of multiscale emergent dynamics in decentralized cell populations
$348,592Neda Bagheri · University Of Washington · · FY2019 · ENG
Mechanisms underlying pro-metastatic effects of estrogen in the brain niche
$348,592Diana M. Cittelly · University Of Colorado Denver · R37 · FY2023 · CA
The CD93 pathway and melanoma therapy
$348,592Yuwen Zhu · University Of Colorado Denver · R01 · FY2023 · CA
Expoitation of ER Stress Induced Immune Dysfunction to Improve Immunotherapy
$348,592Jessica E Thaxton · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$348,526Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2025 · NS
Role of ER-membrane contacts in biogenesis of RNA-containing EVs
$348,504Alissa M Weaver · Vanderbilt University · P01 · FY2020 · CA
Roles of miR-129 in colorecal cancer
$348,425Jingfang Ju · State University New York Stony Brook · R01 · FY2019 · CA
Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin
$348,382Jianhua Yu · Ohio State University · R01 · FY2018 · NS
Surgery triggered immune response and liver metastases
$348,372Allan Tsung · Ohio State University · R01 · FY2021 · CA